Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 45, Issue 12, 2017, Pages 1506-1513

  Krogsgaard, L R ^a,b   Lyngesen, M ^a   Bytzer, P ^a,b  

^a ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN CHILDHOOD DIET; AUSTRALIAN DIET; DIET; FOLLOW UP; HIGH FODMAP DIET; HUMAN; IRRITABLE COLON; LOW FODMAP DIET; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ADMINISTRATION AND DOSAGE; CARBOHYDRATE DIET; DIET THERAPY; FEEDING BEHAVIOR; FERMENTATION; HEALTH CARE QUALITY; IRRITABLE BOWEL SYNDROME; LOW CARBOHYDRATE DIET; METHODOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA;

CARBOHYDRATE DIET; DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYMER; POLYOL;

DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DISACCHARIDES; FEEDING BEHAVIOR; FERMENTATION; HUMANS; IRRITABLE BOWEL SYNDROME; MONOSACCHARIDES; OLIGOSACCHARIDES; POLYMERS; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85018776579     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.14065     Document Type: Review

References (32)

1. Ford AC, Talley NJ. Irritable bowel syndrome. BMJ. 2012;345:e5836.
2. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome– etiology, prevalence and consequences. Eur J Clin Nutr. 2006;60:667-672.
3. Halpert A, Dalton CB, Palsson O, et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol. 2007;102:1972-1982.
4. Böhn L, Störsrud S, Törnblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108:634-641.
5. Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc. 2009;109:1204-1214.
6. Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:707-717.
7. Nelis G, Vermeeren M, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990;99:1016-1020.
8. Barbara G, Cremon C, De Giorgio R, et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315.
9. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75.
10. Peters SL, Yao CK, Philpott H, et al. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44:447-459.
11. Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2015;55:897-906.
12. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
13. Kaptchuk TJ. Effect of interpretive bias on research evidence. BMJ. 2003;326:1453-1455.
14. Eswaran SL, Chey WD, Han-Markey T, et al. A United States, randomized, controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in adults with IBS-D. Gastroenterology. 2016;111:1824-1832.
15. Mcintosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS : a randomised controlled trial. Gut. 2016;doi: 10.1136/gutjnl-2015-311339.
16. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149:1399-1407.
17. Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther. 2015;42:418-427.
18. Pedersen N, Andersen NN, Végh Z, et al. Ehealth : low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014;20:16215-16226.
19. Staudacher HM, Lomer MCE, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510-1518.
20. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1366-1373.
21. Chumpitazi BP, Hollister EB, Oezguen N, et al. Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes. 2014;5:165-175.
22. Irvine EJ, Tack J, Crowell DM, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2016;150:1469-1480.
23. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity following dietary reduction of low-fermentable, poorly-absorbed, short-chain carbohydrates. Gastroenterology. 2013;145:320-328.
24. McKenzie YA, Alder A, Anderson W, et al. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet. 2012;25:260-274.
25. Lee HH, Choi YY, Choi M-G. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2014;20:152-162.
26. Videlock EJ, Cheng V, Cremonini F. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constispation. Clin Gastroenterol Hepatol. 2013;11:1084-1092.
27. Shepherd SJ, Parker FC, Muir JG, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6:765-771.
28. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17:332-340.
29. Enck P, Horing B, Weimer K, et al. Placebo responses and placebo effects in functional bowel disorders. Eur J Gastroenterol Hepatol. 2011;24:1-8.
30. Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010;32:144-158.
31. Horing B, Weimer K, Muth ER, et al. Prediction of placebo responses: a systematic review of the literature. Front Psychol. 2014;5:1-10.
32. Maagaard L, Ankersen DV, Végh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016;22:4009-4019.